# Cyclobenzaprine Extended Release (ER) for Fibromyalgia

> **NCT01041495** · PHASE4 · TERMINATED · sponsor: **State University of New York - Upstate Medical University** · enrollment: 37 (actual)

## Conditions studied

- Fibromyalgia
- Pain
- Sleep
- Fatigue

## Interventions

- **DRUG:** cyclobenzaprine ER (AMRIX)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01041495
- **Lead sponsor:** State University of New York - Upstate Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 37 (ACTUAL)
- **Why stopped:** ran out of funding short of enrollment expected
- **Last updated:** 2024-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01041495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01041495, "Cyclobenzaprine Extended Release (ER) for Fibromyalgia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01041495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*